12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Company News  |  Other News

Daiichi Sankyo, Ranbaxy generics, biosimilars news

Generics company Ranbaxy said it will set aside $500 million to resolve all potential civil and criminal liability in connection with an investigation by the U.S....

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >